Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?

Davide Angeli 1, Samanta Salvi 2, Gianluca Tedaldi 2

Affiliations

PMID: 32046255
DOI: 10.3390/ijms21031128

Abstract

Breast and ovarian cancers are some of the most common tumors in females, and the genetic predisposition is emerging as one of the key risk factors in the development of these two malignancies. BRCA1 and BRCA2 are the best-known genes associated with hereditary breast and ovarian cancer. However, recent advances in molecular techniques, Next-Generation Sequencing in particular, have led to the identification of many new genes involved in the predisposition to breast and/or ovarian cancer, with different penetrance estimates. TP53, PTEN, STK11, and CDH1 have been identified as high penetrance genes for the risk of breast/ovarian cancers. Besides them, PALB2, BRIP1, ATM, CHEK2, BARD1, NBN, NF1, RAD51C, RAD51D and mismatch repair genes have been recognized as moderate and low penetrance genes, along with other genes encoding proteins involved in the same pathways, possibly associated with breast/ovarian cancer risk. In this review, we summarize the past and more recent findings in the field of cancer predisposition genes, with insights into the role of the encoded proteins and the associated genetic disorders. Furthermore, we discuss the possible clinical utility of genetic testing in terms of prevention protocols and therapeutic approaches.

Keywords: cancer predisposition; cancer risk; gene panels; hereditary breast and ovarian cancer; next-generation sequencing.

Similar articles

Recommendations for Preventive Care for Women With Rare Genetic Cause of Breast and Ovarian Cancer
L Foretová et al. Klin Onkol 32 (Supplementum2), 6-13. Summer 2019. PMID 31409076. - Review
An inherited predisposition to breast cancer underlies 5-10% of breast tumors. High-risk BRCA1 and BRCA2 genes result in an 85% lifetime risk of breast cancer and a 20-60 …
[The French Genetic and Cancer Consortium Guidelines for Multigene Panel Analysis in Hereditary Breast and Ovarian Cancer Predisposition]
J Moretta et al. Bull Cancer 105 (10), 907-917. Oct 2018. PMID 30268633.
The expertise of each 18 genes was based on clinical utility criteria, i.e. a relative risk of cancer of 4 and more, available medical tools for screening and prevention …
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
FJ Couch et al. JAMA Oncol 3 (9), 1190-1196. 2017. PMID 28418444.
This study establishes several panel genes as high- and moderate-risk breast cancer genes and provides estimates of breast cancer risk associated with pathogenic variants …
Pathogenic and Likely Pathogenic Variants in PALB2, CHEK2, and Other Known Breast Cancer Susceptibility Genes Among 1054 BRCA-negative Hispanics With Breast Cancer
JN Weitzel et al. Cancer 125 (16), 2829-2836. 2019. PMID 31206626.
Of 1054 BRCA-negative, high-risk Hispanic women, 4.5% carried a PV in a cancer susceptibility gene, increasing understanding of hereditary BC in this population. Recurren …
Women at High Risk of Breast Cancer: Molecular Characteristics, Clinical Presentation and Management
Z Kleibl et al. Breast 28, 136-44. Aug 2016. PMID 27318168. - Review
The presence of breast cancer in any first-degree female relative in general nearly doubles the risk for a proband and the risk gradually increases with the number of aff …